Business

Can Ketamine Treat Depression? Meet Delic, the LARGEST Ketamine Clinic Company

In today’s episode, I talk with Matt Stang, CEO of Delic Corp. Delic (OTCMKTS: DELCF) is a psychedelic medicines company aiming to put a dent in the mental health crisis. They are doing this in three ways. First, through their ketamine clinics. Delic runs the largest ketamine network in the world, with dozens of clinics across North America. At the moment, these clinics are only providing ketamine therapy for disorders like depression, but in the future, once they become legal, Delic also plans on offering other psychedelic therapies such as psilocybin and MDMA therapy. Second, through education. Delic runs multiple media platforms, such as RealitySandwich.com. These media platforms aim to educate and entertain, leading towards the destigmatization of psychedelics in our culture. As many of the people behind Delic Corp were behind the legendary High Times Magazine, this is an area of expertise for the company. Ultimately, psychedelic compounds will never succeed as medicines if society does not get behind them. Delic also has podcasts, and they host psychedelic medicine events. And third, through science. Delic Labs is currently working on creating next generation psychedelics. Delic Labs also works with third parties, completing research, which allows the labs to run on a profit. Taken together, Delic is not only a core player in the psychedelics movement, but they are also one of the companies making a solid revenue. Enjoy the episode! Follow us on social media! Instagram: @thepsychedelicinvestor Facebook: @thepsychedelicinvestor James’ Twitter: @Psy_Invest Maria’s Twitter (Producer & Editor): @Psy_Holy Want to collaborate? Send us an email at: thepsychedelicinvestor@gmail.com Video editing: @themyaholy @Psy_holy DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. Full Disclosure: This video is for entertainment only and shouldn't be taken as investment advice, Pursuant to an agreement between The Psychedelic Investor, Psychedelic Spotlight, and a third party. Psychedelic Spotlight and The Psychedelic Investor were hired for this video, on December 3rd, 2021, to publicly disseminate information about (DELIC CORP) via digital communications. We have been paid ($2000 CAD). #Delic #Psychedelics #Ketamine

Scientists Create A New DMT: Can it Treat Depression? | Psychedelic Therapy

Scientists Create A New DMT: Can it Treat Depression? | Psychedelic Therapy When it comes to treating mental health conditions with psychedelic therapy, one of the most promising compounds is DMT, the main ingredient in the brew ayahuasca. While DMT may have many potential advantages over other similar compounds such as psilocybin, for example, its short duration of effect, the hallucination can be very intense. It is an open question whether the mental health benefits we see from psychedelic therapy are due to the experience one undergoes when having a hallucination, or whether it comes strictly from the drug’s effects on the brain. If it is the latter, then hypothetically speaking, we could create a version of DMT that does not cause a hallucination. Enter Psilera Biosciences. Psilera is a psychedelic medicines company working to create next-generation psychedelics for use in therapeutic settings. Specifically, they aim to create non-psychedelic versions of classical psychedelics such as psilocybin, LSD and DMT. PSIL-002 is Psilera’s version of non-hallucinogenic DMT. They recently completed a pre-clinical trial in mice that showed that their version of DMT was safe and non-psychedelic. Now they have to show that their version of DMT can treat depression and addiction, starting with alcoholism. If Psilera’s DMT can treat these mental health conditions equally as well as regular DMT, but without the intense hallucination, then PSIL-002 would probably be the better compound. It is exciting to see Psilera’s scientists working on answering the following questions: Can DMT treat depression? Can psychedelics help with depression? Can psychedelics help with Mental Health? Enjoy the episode! Follow us on social media! Instagram: @thepsychedelicinvestor Facebook: @thepsychedelicinvestor James’ Twitter: @Psy_Invest Maria’s Twitter (Producer & Editor): @Psy_Holy Want to collaborate? Send us an email at: thepsychedelicinvestor@gmail.com Video editing: @themyaholy @Psy_holy #DMT #DEPRESSION #PSYCHEDELICTHERAPY

Psychedelic Business Spotlight – December 10

,
This week in psychedelic business news: Wesana Health files a new patent, Silo Pharma is granted a patent, and 2 companies explore a merger.
Non-Hallucinogenic DMT? Psilera Bioscience Reports Progress on 'Well-Tolerated' Derivative

Non-Hallucinogenic DMT? Psilera Bioscience Reports Progress on ‘Well-Tolerated' Derivative

,
Further in vivo studies with PSIL-002 will evaluate its antidepressant, anxiolytic, and anti-addictive properties, specifically targeting alcohol consumption.

What are the Benefits of MICRODOSING Psilocybin? | Interview with a Microdosing Expert

What are the benefits of Microdosing psilocybin? | Interview with a Microdosing Expert In today’s episode, we sit down with microdosing expert Sena Maria of The Medicine of Being Human and MicrodosingForResilience.com.  In this interview, we learn about Sena’s microdosing business, which helps people begin microdosing psilocybin (note she does not provide any illegal substances, only coaches people on how to microdose) and the benefits that microdosing can bring. For example, Sena gives us a fantastic Top 5 Benefits of Microdosing at some point in our chat. Some of the questions that we covered were:  -What is microdosing and what are the benefits? -How/ why did you start microdosing ? -What is your microdosing regiment?  -What benefits have you personally seen from this? -What do you wish people knew about psychedelics that they don't currently? -Can Microdosing magic mushrooms help with addiction? -Can microdosing help treat depression or anxiety?   On top of discussing the how and why of microdosing psychedelics, Sena also discussed how these medicines have been known for generations in some aboriginal tribes, and how Western Medicine may still have a lot to learn. Timestamps 00:00- Intro 1:32 - Sena Maria's journey to microdosing: From Google to Psychedelics 4:15- Microdosing For Resilience 5:58- How to microdose psilocybin 8:20- Top 5 benefits of Microdosing 13:31- What is missed in the psychedelics conversation? 18:34- Sena's Psychedelic Ceremony experiences 22:05 - How did you integrate what you learned in your psychedelic ceremony #Microdosing #MicrodosingBenefits #Psychedelics

Psychedelic Business Spotlight: December 3

,
This week in psychedelic business news: MAPS pioneers new funding structure; FDA green lights a Cybin study for Covid-19 distress; Compass Pathways gets new majority stakeholder.

Dr. Matthew Johnson discusses Psychedelics, the Hard Problem of Consciousness and UFOs

During our time in Wonderland Miami, we had the pleasure to meet and interview Dr. Matthew Johnson of Johns Hopkins University. In this Psychedelic Spotlight Interview, we discuss a wide range of topics surrounding psychedelics and their effectiveness as treatments for ailments like tobacco addiction and PTSD. Of course, our conversation took as spin as we also touched on topics such as UFOs, DMT experiences and the CIA! Timestamps: 0:00 - Intro 1:10 - Dr. Johnson's latest updates on treating smoking cessation with psilocybin 6:55 - MAPS' study using MDMA to treat PTSD 7:20 - DMT'S mystical experiences of perceiving aliens, machine elves and autonomous beings 13:08 - CIA research on psychedelics for telepathy and remote viewing 15:01 - What is consciousness? 19:02 - The intriguing evidence of UFOs? 21:40 - Where do we see psychedelics going in the next 5 years? Make sure to like, share and subscribe if you enjoyed this episode! #Psychedelics #MatthewJohnson #UFO
Compass Pathways Releases Promising New Data from Landmark Psilocybin Therapy TrialShutterstock.com

Compass Pathways Releases Promising New Data from Landmark Psilocybin Therapy Trial

Chief Medical Officer Dr. Guy Goodwin clarifies "COMP360 psilocybin therapy was generally well-tolerated" by patients with treatment-resistant depression, despite some adverse reactions from subjects in the study.

Can Psychedelics Treat Alcoholism? New Psilocybin & DMT Studies Say YES!

Can Psychedelics Treat Alcoholism? New Psilocybin & DMT Studies Say YES Wakeful Travel Kickstarter: https://www.kickstarter.com/projects/920110985/wakeful-travel-journals-support-your-transformation?ref=f1y202 In today's episode, we dive into two pre-clinical studies testing psychedelics' effectiveness in treating alcohol-related illnesses. In the first, researchers tested psilocybin (magic mushrooms) on mice who got addicted to alcohol. They found that the psilocybin helped repair a part of their brain that alcohol abuse damaged. This helped the mice make less neurotic decisions, and helped them abstain from alcohol. This is promising, and if it can be repeated in humans, it would be a huge step forward in treating alcoholism. The second study looked at the Ayahuasca brew, which has as its main psychoactive ingredient DMT. In this study, the researchers found that the mice who took the ayahuasca were less likely to seek out more alcohol. Again, if this can be replicated in humans, it would show the powerful benefits of psychedelic medicines to treat alcoholism. Psychedelics and mental health have long been a topic of research, and we are finally getting data that psychedelics like psilocybin and DMT may be effective in treating a variety of mental health conditions, such as alcoholism. Links: Psilocybin Study https://www.science.org/doi/10.1126/sciadv.abh2399#F5 Psilocybin article https://www.inverse.com/mind-body/psilocybin-repairs-alcohol-brain-damage Ayahuasca study: https://pubmed.ncbi.nlm.nih.gov/34822961/ Enjoy the episode! Follow us on social media! Instagram: @thepsychedelicinvestor Facebook: @thepsychedelicinvestor James’ Twitter: @Psy_Invest Maria’s Twitter (Producer & Editor): @Psy_Holy Want to collaborate? Send us an email at: thepsychedelicinvestor@gmail.com Music from: www.bensound.com Video editing: @themyaholy DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. #Psilocybin #DMT #Psychedelics

© 2023 Psychedelic Spotlight. | Owned and operated by PSYC Media Corporation, Inc. a US publicly traded company (OTCPink: PSYC) | All Rights Reserved.